New eye drug shows promise for diabetic retinopathy in phase 2 trial
NCT ID NCT05681884
First seen Mar 20, 2026 · Last updated May 08, 2026 · Updated 8 times
Summary
This study tested a drug called faricimab in 179 adults with non-proliferative diabetic retinopathy, a diabetes-related eye condition that can lead to vision loss. The goal was to see if monthly injections of faricimab could improve blood flow in the retina over 48 weeks compared to observation alone. The trial is now complete, and results will help determine if this treatment can slow or stop disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Retina Associates
Austin, Texas, 78705, United States
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
Charleston Neuroscience Institute
Ladson, South Carolina, 29456, United States
-
Florida Retina Institute
Orlando, Florida, 32806, United States
-
Long Island Vitreoretinal Consultants
Westbury, New York, 11590, United States
-
Mississippi Retina Associates
Jackson, Mississippi, 39202, United States
-
North Carolina Retina Associates
Wake Forest, North Carolina, 27587, United States
-
Palmetto Retina Center
West Columbia, South Carolina, 29169, United States
-
Retina Consultants of Minnesota St. Louis Park
Saint Louis Park, Minnesota, 55416, United States
-
Retina Consultants of Texas
Beaumont, Texas, 77707, United States
-
Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Retina Consultants of Texas
Katy, Texas, 77494, United States
-
Retina Consultants of Texas
San Antonio, Texas, 78240, United States
-
Retina Consultants of Texas
The Woodlands, Texas, 77384, United States
-
Retina Group of Florida
Sarasota, Florida, 34233, United States
-
Retinal Consultants Medical Group
Modesto, California, 95356, United States
Conditions
Explore the condition pages connected to this study.